In addition to flow-through shares, Canada works on a number of leading innovative sectors, and it boasts a world-class portfolio of research organizations and leading companies developing innovative vaccines for debilitating diseases.
Our companies are doing much to help Canadians and Canada's health care system. In 2003 the federal government launched the national immunization strategy, which has since contributed approximately $100 million a year in federal funding toward immunization programs for new vaccines related to chicken pox, pneumococcus, adolescent whooping cough, meningitis, and HPV-related diseases.
We need you to keep building on the success of the NIS program, to create a permanent fund of a minimum $100 million per year to ensure newly recommended vaccines can reach all Canadians. The investment will not only save lives, but it will send a signal to the world that Canada remains at the forefront of vaccine discovery.